Alaunos Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 21.35 K | $51.46 K | 0.00% | 1.27% |
| VANGUARD GROUP INC | 11/07/2025 | 20.97 K | $51.17 K | 0.00% | 1.25% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 15.79 K | $38.54 K | -0.97% | 0.94% |
| MORGAN STANLEY | 11/14/2025 | 1.68 K | $4.06 K | -6.34% | 0.10% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.63 K | $3.94 K | 67.83% | 0.10% |
| UBS GROUP AG | 11/13/2025 | 1.53 K | $3.70 K | -77.51% | 0.09% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 1.17 K | $2.81 K | 67.63% | 0.07% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/24/2025 | 300 | $723 | 0.00% | 0.02% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 183 | $441 | 0.00% | 0.01% |
| RONALD BLUE TRUST, INC. | 10/16/2025 | 135 | $325 | 100.00% | 0.01% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/12/2025 | 92 | $222 | -91.62% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 89 | $214 | 4.71% | 0.01% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/14/2025 | 70 | $169 | -18.60% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 50 | $121 | 100.00% | 0.00% |
| ASSET DEDICATION, LLC | 11/20/2025 | 46 | $111 | 0.00% | 0.00% |
| KEY FINANCIAL INC | 11/05/2025 | 24 | $60 | 0.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 11/13/2025 | 24 | $58 | 0.00% | 0.00% |
| SIGNATUREFD, LLC | 10/21/2025 | 23 | $55 | 0.00% | 0.00% |
| NBC SECURITIES, INC. | 11/14/2025 | 20 | $48 | 100.00% | 0.00% |
| ADVISORNET FINANCIAL, INC | 10/09/2025 | 19 | $46 | 0.00% | 0.00% |
| SUNBELT SECURITIES, INC. | 11/19/2025 | 10 | $24 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 6 | $15 | 0.00% | 0.00% |
| WEALTHSPIRE ADVISORS, LLC | 11/14/2025 | 1 | $3 | 100.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 11/14/2025 | 1 | $2 | 0.00% | 0.00% |
| BOKF, NA | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 0 | $0 | -100.00% | 0.00% |
| THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. | 10/07/2025 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| INVESTMENT MANAGEMENT CORP /VA/ /ADV | 10/30/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alaunos Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 96 institutional investors and hedge funds held shares of Alaunos Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 21,353
VANGUARD GROUP INC: 20,972
GEODE CAPITAL MANAGEMENT, LLC: 15,791
MORGAN STANLEY: 1,684
Tower Research Capital LLC (TRC): 1,633
UBS Group AG: 1,533
3.89% of Alaunos Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 13.76 M shares in the last 24 months. This purchase volume represents approximately $35.77 M in transactions.